|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CRVO | ALAM JOHN J | CEO & President | Nov 12 '25 | Buy | 7.35 | 5,553 | 40,815 | 1,467,131 | Nov 13 08:52 AM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Oct 01 '08 | Option Exercise | 13.63 | 4,253 | 57,968 | 141,045 | Oct 02 11:02 AM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Oct 01 '08 | Sale | 32.65 | 4,253 | 138,860 | 136,792 | Oct 02 11:02 AM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Sep 10 '08 | Option Exercise | 10.19 | 6,614 | 67,397 | 143,406 | Sep 11 04:24 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Sep 10 '08 | Sale | 26.23 | 6,614 | 173,485 | 136,792 | Sep 11 04:24 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Sep 03 '08 | Option Exercise | 10.19 | 6,612 | 67,376 | 143,404 | Sep 04 04:14 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Sep 03 '08 | Sale | 25.86 | 6,612 | 170,986 | 136,792 | Sep 04 04:14 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Aug 27 '08 | Option Exercise | 10.19 | 6,612 | 67,376 | 143,404 | Aug 28 01:19 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Aug 27 '08 | Sale | 27.02 | 6,612 | 178,656 | 136,792 | Aug 28 01:19 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Aug 20 '08 | Option Exercise | 10.19 | 6,612 | 67,376 | 143,404 | Aug 21 01:52 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Aug 20 '08 | Sale | 27.57 | 6,612 | 182,302 | 136,792 | Aug 21 01:52 PM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | Jun 19 '08 | Option Exercise | 15.76 | 8,281 | 130,486 | 136,792 | Jun 23 11:21 AM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | May 20 '08 | Sale | 27.59 | 722 | 19,918 | 128,591 | May 22 09:24 AM |
| VRTX | ALAM JOHN J | EVP, Med. Dev. Group & CMO | May 21 '08 | Sale | 27.89 | 80 | 2,231 | 128,511 | May 22 09:24 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite